Advertisement
Singapore markets closed
  • Straits Times Index

    3,285.95
    +20.00 (+0.61%)
     
  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • FTSE 100

    8,442.00
    +60.65 (+0.72%)
     
  • Bitcoin USD

    62,879.76
    +1,680.06 (+2.75%)
     
  • CMC Crypto 200

    1,305.35
    -52.66 (-3.88%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • Dow

    39,387.76
    +331.36 (+0.85%)
     
  • Nasdaq

    16,346.26
    +43.46 (+0.27%)
     
  • Gold

    2,380.00
    +39.70 (+1.70%)
     
  • Crude Oil

    79.55
    +0.29 (+0.37%)
     
  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     
  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     
  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     
  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

BHC and Teva: How Free Cash Flow and Net Debt Stack Up

BHC and Teva: How Free Cash Flow and Net Debt Stack Up

Bausch Health or Teva: Which Is a Better Pharmaceutical Bet?(Continued from Prior Part)Free cash flow projections Bausch Health Companies (BHC) and Teva Pharmaceutical (TEVA) reported free cash flow of $1.27 billion and $1.79 billion, respectively,